DNA X reports FY2025 no revenue from continuing ops; closes mobile asset sale for $15M

DNA X, Inc.

No revenue from continuing operations in Q4 2025; G&A expenses $1.2M primarily for acquisition and sale costs.
Completed sale of mobile device assets to NEXA Mobility on Jan 23, 2026 for $15M; $13.5M paid immediately.
CEO and board member resigned Jan 30, 2026; Executive Chairman Mike Mulica named acting CEO; Scott Walker appointed to board.
Cash from continuing ops $1.3M at Dec 31, 2025; proceeds used to repay debt and support DNA X crypto platform.
Rebranded as DNA X, Inc. from Sonim Technologies; Nasdaq ticker remains SONM.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DNA X, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue There was no revenue from continuing operations.

Period: the fourth quarter and full year ended December 31, 2025
Revenue: There was no revenue from continuing operations
Result: reported results

Exact text from the filing

On April 14, 2026, DNA X, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended December 31, 2025

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

DNA X, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-016655

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.